Effects of GlucoClear CGM System on the Performance of Insulin Therapy in Critically Ill Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

June 30, 2015

Conditions
Metabolic Stress Hyperglycemia
Interventions
DEVICE

Intravascular continuous monitoring

Bedside usual insulin therapy guided by continuous glucose monitoring

OTHER

Standard of care

Bedside usual insulin therapy guided by intemittent glucose monitoring

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Edwards Lifesciences

INDUSTRY

lead

Erasme University Hospital

OTHER